Patients News | pharmaphorum

News

AstraZeneca's oral drug Truqap will soon be available for people with advanced breast cancer via the NHS in England, as long as testing is available.

News

The first targeted drug for a common form of bladder cancer that can be taken at home. J&J's Balversa, has been backed for NHS use.

News

HHS has said it plans to appeal a permanent injunction on big cuts to indirect funding for medical research awarded by the NIH.

News

The first biosimilars of AstraZeneca/Alexion's blockbuster complement C5 inhibitor Soliris have been launched in the US at a discount to the brand.

News

The US is close to falling behind China in biotech and the government should spend a minimum of $15bn over the next five years to support the sector.

News

AbbVie has picked up another indication for its JAK inhibitor Rinvoq in the EU, becoming the first approved oral therapy for giant cell arteritis.